Drosophila: a fruitful model for calcium oxalate nephrolithiasis?  by Knauf, Felix & Preisig, Patricia A.
commentar yhttp://www.kidney-international.org
© 2011 International Society of Nephrology
Kidney International (2011) 80    327
 Nephrolithiasis is the second most com-
mon kidney disease and a known risk fac-
tor of chronic kidney disease. How ever, 
the pathophysiology of nephro lithiasis 
remains poorly understood, and there 
have been few, if any, advances in the 
treatment of kidney stones in years. Th us, 
the development of new animal models 
of stone disease may allow for a better 
understanding of the pathophysiology 
underlying urolithiasis and open oppor-
tunities for new therapeutic approaches. 
 The prevalence of kidney stones has 
been increasing in parallel with other epi-
demics, such as obesity, diabetes mellitus, 
hypertension, and the metabolic syn-
drome, associated with the development 
of Western cultures. 1 Calcium oxalate 
(CaOx) is the predominant type of kidney 
stone disease, occurring in the majority 
of the kidney stone population in the 
United States. 2 
 It is estimated that kidney stones 
account for more than  $ 5 billion per year 
in economic costs in the United States for 
hospitalizations, stone removal, and time 
lost from work. 3 Despite the high preva-
lence and cost of nephrolithiasis and the 
frequent recurrence aft er the fi rst stone, 
our understanding of how genetic, envi-
ronmental, and metabolic factors act sin-
gly or in concert to trigger stone formation 
remains patchy, and the progress of med-
ical therapy has been very modest. In idi-
opathic hyperoxaluria, which is present in 
40 % of stone formers, no proven pharma-
cotherapy has been established. 4 Th ere-
fore, basic research directed at model 
systems that elucidate the pathophysiol-
ogy of CaOx stone disease in combination 
with clinical research is the best hope for 
advancing the field and leading to the 
development of new therapeutic 
approaches that have the potential to 
reduce the morbidity, mortality, and cost 
associated with this disease. 
 Chen and colleagues 5 (this issue) now 
present a new model of CaOx nephro-
lithiasis in the fruitfl y  Drosophila mela-
nogaster . In  Drosophila , the Malphigian 
tubules are considered the fl y kidney and 
represent the excretory and osmoregula-
tory system. However, unlike the verte-
brate kidney, the  Drosophila kidney does 
not have a glomerular-like structure, so 
the luminal fl uid is not generated by a fi l-
tration process. 6  Figure 1 is a schematic 
diagram of the Malphigian tubule system 
showing the absence of a glomerular-like 
structure, but the secretion of salts, water, 
and waste products into blunt-end tubular 
structures and the emptying of the tubular 
contents into the gastrointestinal system, 
where reabsorptive processes represent 
the fi nal regulation of water and nutrient 
excretion. As indicated in  Figure 1 , Chen 
 et al. 5 fed fruitfl ies three lithogenic agents: 
ethylene glycol (EG), hydroxyl- l -proline 
(HLP), and sodium oxalate (NaOx). Polar-
ized light microscopic analysis of dis-
sected tubules demonstrated that EG, 
HLP, and NaOx feeding resulted in crystal 
formation within the lumen of the tubule 
in a dose-dependent manner. By energy-
dispersive X-ray spectroscopy and scan-
ning electron microscopy, these crystals 
were identifi ed as CaOx stones. In a sub-
sequent series of experiments, the inves-
tigators demonstrated that EG-induced 
crystal formation reduced lifespan in  Dro-
sophila and that the addition of the litho-
lytic agent potassium citrate (KCit) 
reduced the EG-induced stone formation 
and re-extended the fl ies ’ lifespan. On the 
basis of these data, the authors present 
 Drosophila as a new model for experimen-
tal induction and treatment of CaOx 
nephrolithiasis. 
 Th e addition of an insect model for elu-
cidating the pathophysiology underlying 
stone disease and potentially developing 
new therapeutic approaches expands the 
repertoire of model systems, which have 
been primarily mouse and rat systems. 7 
Th ere are advantages of the  Drosophila 
system that should be noted, namely, (1) 
the low cost of maintaining  Drosophila 
colonies, (2) the rapid deployment of new 
transgenic lines, and (3) the ability to test 
hypotheses in lower-species  in vivo sys-
tems before embarking on studies in more 
cumbersome higher-order animals. 6 
 However, the limitations should also 
be noted. Th e key limitation is that the 
insect system is aglomerular, and thus 
the composition of the fi nal tubular fl uid 
is based entirely on active secretion 
rather than ultrafi ltration followed by a 
combination of reabsorption and secre-
tion. 8 Th e absence of a fi ltration structure 
is explained by the physical relationship 
between the blood supply and the 
tubules: the tubules freely fl oat in the 
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hemocoel (blood-filled body cavity) 
rather than having a vascular system that 
hugs the tubules, as in the mammalian 
renal system. 
 The difference in the way filtrate is 
formed in insect tubules may be a 
key limitation to understanding the 
mechanism(s) involved in CaOx nephro-
lithiasis in mammals. Mice defi cient in 
the oxalate transporter SLC26A6 demon-
strate hyperoxalemia and hyperoxaluria 
and have CaOx stones on the basis of a 
defect in intestinal back-secretion of 
ingested oxalate. 9,10 In the kidney, 
SLC26A6 is responsible for chloride –
 oxalate exchange resulting in active chlo-
ride absorption and oxalate secretion in 
the proximal tubule. 11 Th us, it would be 
predicted that loss of chloride – oxalate 
exchange activity in the kidney would 
result in reduced oxalate excretion; 
however, increased oxalate excretion is 
observed and can be explained as follows: 
Th e defect in intestinal secretion leads to 
an increase in plasma oxalate concentra-
tion, which in turn leads to an increase in 
the filtered load of oxalate. Since the 
resulting hyperoxaluria can be accounted 
for by the increase in the fi ltered load of 
oxalate, these results are interpreted to 
mean that oxalate fi ltration, rather than 
secretion, is the primary determinant of 
oxalate excretion. Th us, an insect model 
in which urine composition is based on 
secretion rather than fi ltration may lead 
to the opposite results when compared 
with a mammalian model. 
 In clinical practice, the cornerstone of 
the evaluation of recurrent stone formers 
includes an analysis of both plasma values 
and urine biochemistry, obtained from a 
24-h urine collection. The  Drosophila 
model used by Chen and colleagues 5 lacks 
information on urinary or serum (hemo-
lymph) biochemistry and thus leaves their 
fi ndings largely phenomenological. 
 Th e observation that the EG-fed fl ies 
demonstrated an increased incidence of 
CaOx stones and reduced lifespan does 
not allow any causal conclusions. In fact, 
a known side eff ect of EG treatment is 
metabolic acidosis. 12 Th us, it is conceiv-
able that EG feeding results in a chronic 
metabolic acidosis, and that this is the 
cause of the shortened lifespan and not 
the higher incidence of stone formation. 
Th e investigators tested the eff ect of a 
litholytic agent in their  Drosophila model 
and were able to demonstrate that 
administration of KCit decreases kidney 
stone formation and increases the fl y ’ s 
lifespan as compared with that of fl ies fed 
EG alone. 
 Assuming that the luminal fl uid in Mal-
phigian tubules contains citrate and that 
the amount of secreted citrate is regulated 
by pH, the litholytic eff ect of KCit may be 
secondary to correction of the hypocitra-
turia caused by the EG-induced metabolic 
acidosis. Raising the tubular fl uid citrate 
concentration may have contributed to 
the reduced rate of stone formation by 
binding the tubular fl uid Ca 2 +  , which itself 
may have increased secondarily to the 
chronic metabolic acidosis, leaving less 
free Ca 2 +  available to combine with 
oxalate. In addition, the benefi cial eff ect 
of a higher  luminal [citrate] may be sec-
ondary to inhi bition of crystal agglom-
eration itself, as demonstrated in  in vitro 
models. 13 Lastly, the litholytic eff ect of 
KCit may be completely unrelated to cit-
rate but rather secondary to a higher 
potassium intake, which in and of itself 
has been shown to reduce stone formation 
by reducing urinary Ca 2 +  excretion. 14 
Without urinary and blood / hemolymph 
biochemistry data these questions will 
remain unanswered and the mechanism 
of CaOx formation in this model unre-
solved. 
 So is  Drosophila a fruitful model of 
CaOx stone disease? Th e ease and power 
of genetics in this model cannot be over-
estimated with regard to its potential for 
helping us identify genes involved in stone 
pathogenesis, especially when combined 
with already established mouse and rat 
models. However, a  ‘ great ’ model is one 
that imitates or exactly copies the real 
situation, in this case the nephrolithiasis. 
Whether the  Drosophila model is able to 
mimic human nephrolithiasis needs to be 
seen. Diff erences in tubular fl uid forma-
tion and diffi  culties in following plasma 
values and urine biochemistry may be the 
ultimate limitations of this model. 
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 Figure 1  |  Model for studying kidney stone formation in the  Drosophila model.  Drosophila 
melanogaster was fed the hyperoxaluria-causing agents ethylene glycol (EG), hydroxyl- L -proline 
(HLP), and sodium oxalate (NaOx). Malphigian tubules in combination with the intestine that they 
drain into are considered the fruitfly renal system, as together they are responsible for regulation of 
salt, water, and nitrogenous waste excretion and maintenance of a homeostatic physiological state. 
Following the administration of lithogenic agents, stones were identified within the Malphigian 
tubules by polarized light microscopy. Analysis of the stones by elemental composition of the 
crystals identified the stones as calcium oxalate stones. 
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 Adenosine A 2A agonists as 
therapy for glomerulonephritis 
 David A.  Ferenbach 1 and  Jeremy  Hughes 1 
 Garcia  et al. report the utility of pharmacological activation of the 
adenosine A 2A receptor (A 2A R) in preserving renal function, reversing 
fibrosis, and reducing macrophage infiltration and inflammatory 
activation in rat nephrotoxic nephritis. The role of A 2A R activation in 
determining outcome in renal inflammation is discussed. 
 Kidney International (2011)  80, 329 – 331.  doi: 10.1038/ki.2011.167 
 Although macrophage infiltration is 
impor tant in renal injury that includes 
glome rulonephritis, 1 appropriate leukocyte 
recruitment and activation are also a vital 
step in reparative tissue responses. Persistent 
tubulointerstitial and glomerular macro-
phage infi ltration is a hallmark of chronic 
infl ammatory disease and a feature of many 
progressive renal diseases. Immunosuppres-
sion may interrupt the natural history of 
renal inflammatory disease but is often 
incompletely eff ective and is associated with 
treatment-related complications. Th ere is 
much research examining the immune 
mechanisms underlying chronic infl amma-
tion and the associated inade quacy of dis-
ease resolution pathways, and it is hoped 
that identification of some of the cues 
responsible for limiting active infl ammation 
and initiating the resolution phase will lead 
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to novel targeted therapies capable of abort-
ing infl ammatory disease with an improved 
side-eff ect profi le. 
 One putative  ‘ anti-infl ammatory and reso-
lution signal ’ is the release of free extracellular 
adenosine, generated in response to meta-
bolic stress and cell damage in renal ischemia 
or infl ammation. Adenosine A 2A receptors 
(A 2A Rs) are expressed across multiple cell 
lineages  in vivo , including endothelium, epi-
thelium, and multiple leukocyte subsets. 
Ligation of leukocyte A 2A R is associated with 
the opposition of infl ammatory activation; 
hence the adenosine – receptor system can be 
viewed as an elegant endogenous feedback 
system opposing persisting and injurious 
immune activation with promotion of the 
switch to a resolution phenotype. 
 Garcia  et al. 2 (this issue) present work 
detailing the impact of pharmacological 
A 2A R agonism and antagonism on the 
outcome of established proteinuric anti-
glomerular basement membrane (anti-
GBM) nephritis with drug treatment 
commenced 14 days aft er disease initia-
tion. Th e data presented build on their 
previous work showing that A 2A R ago-
nism from the time of disease initiation 
reduced disease severity. 3 Th e initiation of 
treatment in established disease used in 
the current study off ers a better analogy 
to the typical presentation and treatment 
of patients with rapidly progressive 
glomerulonephritis and enhances the 
translational importance of the fi ndings. 
 Garcia  et al. 2 report that the administra-
tion of the A 2A R agonist CGS 21680 has a 
prompt and sustained impact in lessening 
proteinuria and prevents progressive eleva-
tion in serum creatinine. CGS 21680-
treated animals exhibited reduced disease 
severity with a remarkable reduction in 
glomerular macrophage infi ltration associ-
ated with reduced levels of the chemokine 
CCL22 as well as reduced osteopontin, 
thrombospondin, and transforming growth 
factor-  mRNA levels. Notably, in kidneys 
treated with the agonist for 6 days, there 
was a reversal of established fi brosis with 
reduced expression of collagens III and IV 
and reduced interstitial myofibroblast 
accumulation. In contrast, A 2A R antago-
nism worsened disease outcome. 
 Th e mechanistic importance of macro-
phage recruitment in mediating tissue 
injury and subsequent fi brosis in experi-
mental models of renal disease that includes 
anti-GBM nephritis is well recognized, as 
is its contribution to progression of human 
renal disease. Th us it seems likely that the 
marked reduction in macrophage infi ltra-
tion evident in CGS 21680-treated animals 
is of major significance. However, the 
diverse expression profi le of the A 2A R  in 
vivo complicates definitive conclusions 
regarding the key cellular target of CGS 
21680 in mediating the protected pheno-
type reported, and it thus remains possible 
that reduced macrophage infi ltration is an 
epiphenomenon refl ecting reduced tissue 
injury mediated by alternative, possibly 
multiple pathways. In order to draw defi n-
itive conclusions regarding the relative con-
tributions of leukocyte and macrophage 
A 2A R activation to disease phenotype, 
studies involving bone marrow transplan-
tation or cell lineage-restricted A 2A R acti-
vation or deletion will be necessary. 
 THE IMPACT OF A 2A R ACTIVATION ON 
OUTCOME IN EXPERIMENTAL 
INFLAMMATION 
 Th e generation of A 2A R knockout mice 
and the development of pharmacological 
